Pixium Vision (Pixium Vision) Common Stock : $0.00 Mil (As of Jun. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Pixium Vision Common Stock?

Pixium Vision's quarterly common stock increased from Jun. 2022 ($3.72 Mil) to Dec. 2022 ($4.40 Mil) but then declined from Dec. 2022 ($4.40 Mil) to Jun. 2023 ($0.00 Mil).

Pixium Vision's annual common stock increased from Dec. 2020 ($3.21 Mil) to Dec. 2021 ($3.98 Mil) and increased from Dec. 2021 ($3.98 Mil) to Dec. 2022 ($4.40 Mil).

Pixium Vision Common Stock Historical Data

The historical data trend for Pixium Vision's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pixium Vision Common Stock Chart

Pixium Vision Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Common Stock

Get a 7-Day Free Trial

1.47

1.62

3.21

3.98

4.40

Pixium Vision Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Common Stock	Get a 7-Day Free Trial															3.51	3.98	3.72	4.40	-

Pixium Vision Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Pixium Vision (Pixium Vision) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Pixium Vision SA (OTCPK:PXMVD) » Definitions » Common Stock

Comparable Companies

Traded in Other Exchanges

ALPIX:France PXH1:Germany

Address

74 rue du Faubourg Saint Antoine, Paris, FRA, 75012

Website

http://www.pixium-vision.com

Pixium Vision SA is engaged in the business of developing implantable medical devices to treat blindness resulting from the degeneration of retinal photoreceptor cells.

Pixium Vision (Pixium Vision) Headlines

No Headlines